Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.37/Share
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.37), versus ($0.51) reported last year.
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.37), versus ($0.51) reported last year.
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.